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2Abstract 
Presymptomatic testing for hereditary cancer syndromes should involve a 
considered choice. This may be particularly challenging when testing is 
undertaken in early adulthood. With the aim of exploring the psychosocial 
implications of presymptomatic testing for hereditary cancer in young 
adults and their parents, a cross-sectional survey was designed. Two 
questionnaires were developed (one for young adults who had considered 
presymptomatic testing, one for parents). Questionnaires were completed 
by 152 (65.2%) young adults and 42 (73.7%) parents. Data were analysed 
using descriptive statistics, inferential testing, and exploratory factor 
analysis and linear regression analysis. Young adults were told about their 
potential genetic risk at a mean age of 20 years; in most cases, 
information was given by a parent, often in an unplanned conversation. 
Although testing requests were usually made by young adults, the majority 
of parents felt they had control over the young adult’s decision and all felt 
their children should be tested. Results suggest that some young adults 
did not understand the implications of the genetic test but complied with 
parental pressure. Counselling approaches for presymptomatic testing 
may require modification both for young adults and their parents. Those 
offering testing need to be aware of the complex pressures that young 
adults can experience, which can influence their autonomous choices. It is 
therefore important to emphasise to both parents and young adults that, 
although testing can bring benefits in terms of surveillance and prevention, 
young adults have a choice.   
Key Words. 
Decision-making, genetic counselling, hereditary cancer, young adults, 
parents, presymptomatic genetic testing, familial cancer syndromes 
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INTRODUCTION 
Presymptomatic genetic testing (PST) involves testing to determine if a 
person has inherited a gene variant that causes a familial condition, before 
the person has any signs or symptoms of the condition1.  This type of 
testing is available for a number of heritable genetic disorders, including 
some hereditary cancer syndromes1. The results of PST for hereditary 
cancer syndromes may allow individuals to engage in healthy lifestyle 
choices or seek early treatment for symptoms2,3. Some key challenges 
associated with the transition from adolescence to adulthood can include 
completing education, beginning full-time employment, forming 
romantic/sexual relationships, marriage and becoming a parent: the 
impact of testing may affect, and be affected by, each of these events.   
A variety of psychosocial responses have been observed in people who 
have chosen to be tested4–6. Various guidelines and position papers have 
been produced on PST in minors7.  It is clearly suggested that undergoing 
PST too early in life may increase the risk of unfavourable impact, and, 
therefore, the appropriate age to undergo PST is still a matter of debate7–9. 
For these reasons, PST for adult-onset disorders is not generally 
recommended for those aged less than 18 years, unless it is in a child’s 
best interests either in terms of immediate relevance for their health or 
because it involves psychological or social benefits10. Although the 
definition of a young adult (YA) can be extremely broad and is not often 
clear in terms of one specific age group, the definition proposed by 
Rindfuss11 (18- 30 years) was used: 18 years is an age that is often 
recognized in law and 30 years often represents time for taking stock in 
life. Prior to testing, YA need to be aware of the potential risk to them of 
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hereditary cancer, and this is usually disclosed by their parents12–14. A 
systematic review15 on this topic indicated that many YA or adolescents 
(14- 30 years) grew up with little or no information concerning their genetic 
risk and that parents had exerted pressure during the testing decision-
making process.  An empirical qualitative study16 conducted in Italy 
indicated that YA made a decision to be tested before approaching genetic 
services, and had not realised that they could use genetic counselling to 
make a choice. However, the process of genetic counselling enabled them 
to act more autonomously and to adapt to the results. This study was 
designed to build on those results and further explore the psychosocial 
implications of PST for hereditary cancer in YA and their parents. Specific 
objectives were to investigate how YA interpret PST, the reasons for the 
YA’s decision to undergo testing, the experience of the counselling 
process of both YA and parents and the influence that parents have both 
on the choice to be tested and on the YA’s decisions after receiving a 
positive test result. 
MATERIALS AND METHODS 
The study design was a cross-sectional self-completion survey17.  This 
study received ethics approval from both St. Orsola-Malpighi Hospital 
Ethical Board (198/2015/O/Oss), and Plymouth University Faculty 
Research Ethics Committee (15/16-519). 
Recruitment and participants 
To maximise accessibility to the survey, online and traditional methods of 
recruitment and data collection were used. Although online surveys are a 
convenient way of collecting data from a wide range of people18, there is 
evidence that many members of the Italian population do not use the 
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Internet regularly19. Data were collected using: i) online questionnaires 
(Italian and English version) uploaded to the Survey Monkey® website (for 
example using social networks) and ii) paper versions (Italian) of the same 
questionnaire. Traditional recruitment was used only at St. Orsola-Malpighi 
Hospital, Italy, and specific ethical approval was obtained for that. Every 
YA or parent of a YA who had been tested who met the inclusion criteria 
was invited to take part in the study. Parents and YA who responded were 
not necessarily related to each other. The surveys were open to 
respondents between December 2015 and June 2016. Inclusion and 
exclusion criteria and the recruitment flow-chart are presented respectively 
in Figure1 and Figure 2. 
Questionnaire 
Since it was important to investigate both consultands’ (YA aged 18-30 
years11) and parents’ points of view, two questionnaires were designed. 
The questions were based on the results of a systematic review15 and a 
qualitative study of YA’s experiences of PST16 and on other similar 
surveys20,21. The questionnaires were written both in Italian and English 
(English version in supplementary files). 
Data analysis 
In this cross-sectional study, data were entered into a dedicated database 
(Statistical Package for the Social Sciences (SPSS) Ver. 21.0 for 
Windows) (IBM Corporation, Armonk, NY, USA), arranged by variables 
and analysed using descriptive and inferential statistical tests. Descriptive 
statistics were used to determine the mean, standard deviation, 
percentage and frequency of variables. The chi-squared test for 
independence was used to discover if there was a relationship between 
 6
two categorical variables22. The Fisher’s exact test, the independent t-test 
and ANOVA were used to analyse the data inferentially24. Post-hoc tests 
were also performed where appropriate22. Furthermore, exploratory factor 
analysis (EFA) was carried out to reduce the number of variables, by 
identifying a limited number of underlying factors explaining multiple 
observed variables23-25. EFA led to identify 20 factors under 6 main 
questions (Table 1). The factors were also analysed using descriptive 
statistics and hypothesis testing to analyse the data inferentially. Simple 
and multiple linear regression analysis were then used to identify effects of 
independent variables (dummy-coded) on the factors identified by EFA 
(dependent variables); detailed data from multiple linear regression are 
reported in Table 2 (a-e). Throughout the study, results were considered 
statistically significant when the p-value was less than .05. For further 
information on the methods used for statistical analyses, see 
Supplementary files. 
Rigour 
To ensure rigour, a pilot of the survey was conducted with five colleagues, 
in order to test the online surveys and data extraction. The same SPSS 
syntax was used for the analysis to ensure reproducibility, and to allow 
any reader to verify what has been done.  
RESULTS 
Sample characteristics 
Of 233 individuals who logged onto the YA survey site and 57 individuals 
who logged onto the parent survey site, 152 (65.2%) and 42 (73.7%) 
respectively provided both consent and complete data and were included 
in the analysis.  
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Young adult questionnaire results 
The demographic information provided by the study participants is shown 
in Table 3.  The majority of participants (n=142; 93.4%) were variant-
positive, and among those 6.3% (n=9) had been diagnosed with cancer 
since having their PST. The number of females who completed the 
English questionnaire (PEQ) was significantly higher when compared to 
men (134/140, 95.7% versus 7/11, 63.6%; p=.003, Fisher’s exact test).  
Among the PEQ the majority were variant-positive (96.9%) while in the 
Italian sample (PIQ) there were 19 (76.0%) variant-positive and six 
(24.0%) variant-negative respondents (p=.001, Fisher’s exact test).  
Finding out about their risk 
Participants declared they received the information about their risk for the 
first time when between 5-30 years of age (20.0±5.6): 111 (75.5%) were 
informed after their 18th birthday, while 36 (24.5%) were informed earlier.  
Fifty-four YA participants (35.5%) were told by their mother, 19 (12.5%) by 
their father, 16 (10.5%) by both parents together, seven (4.6%) by their 
sister, 24 (15.8%) by other relatives such as aunts or cousins, and 26 
(17.1%) by a person outside the family such as a genetic counsellor or a 
physician. Three participants (2.0%) had suspected they were at risk 
because of a family history of cancer and sought medical advice, and 
three (2.0%) reported the risk was openly discussed within their family. 
One-hundred and two participants (68.5%) reported they received the 
information at an unplanned time (75 in a face-to-face conversation and 27 
in a telephone or social media call/message), while 43 (28.9%) received 
the information in a pre-planned conversation (38 in a face-to-face 
meeting and five in a telephone call).  Two participants did not remember 
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how they received the information. The majority of participants (n=132; 
86.8%) were told at that time that the tendency to cancer in their family 
could be due to a genetic change.  A significant difference was observed 
in relation to the time taken for testing after disclosure: 73.1% of 
participants who had received the information from a person outside the 
family underwent PST within one year of obtaining the information 
(χ2=19.951, df=9, p=.018), compared to 41.7% of those told by a family 
member. Participants who were told about their potential genetic risk 
before their 18th birthday showed lower awareness of their risk (Q1, F1) 
(Betabefore18=-.187, R2=.028, p=.026) and lower need for additional 
information (Q1, F2)  (Betabefore18=-.173, R2=.037, p=.023).  
Decision-making process 
The majority of participants (n=105; 75.5%) responded “myself” when 
asked about the person who decided that they would be tested, while 
“both myself and parents” was mentioned by 23 (16.5%), “parents” by four 
(2.9%), “aunt” by four (2.9%), and genetic counsellor/doctor by three 
(2.2%). The proportion of PEQ reporting the decision as made by 
themselves was significantly higher if compared to PIQ (96/116, 82.8% 
versus 9/23, 39.1%; χ2=38.715, df=4, p<.001). Participants who 
underwent PST within one year of obtaining the information were more 
likely to show proactivity (Q3, F1) than those who underwent PST between 
two and four years after (3.9±0.9 versus 3.2±1.3; F=2.987, p=.034). 
Becoming aware of potential genetic risk before age 18 or being informed 
by distant relatives predicted a lower perception of parents’ pressure 
against testing (Q3 F2) (Betabefore18=-.220, Betaother-relatives=-.617), unlike 
being tested between 18-25 years of age, that predicted higher perception 
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of parents disagreement about testing (Betabefore25=.260) (F(11,90)=2.028, 
p=.034). Men were found more likely than women to have undergone 
genetic testing because of their parent’s decision both using variance 
analysis (3.4±1.3 versus 1.6±1.4; t(135)=4.640, p<.001) and multiple linear 
regression (Betafemale=.410). Pressure from parents toward testing was 
reported more frequently by participants without children than by those 
who had children (3.1±1.4 versus 2.5±1.4; t(134)=-2.771, p=.006), with a 
correlation confirmed by multiple linear regression (Betawith-children=-.264). 
Also, participants who became aware of their risk before age 18 were less 
likely to undergo PST upon their parents’ decision (Q3,F3) (Betabefore18=-
.183) (F(11,110)=4.368, p<.001). Pressure by parents was more 
frequently reported by participants tested between 18-25 years than by 
those undergoing genetic testing between 26-30 years of age (3.0±1.4 
versus 2.5±1.4; t(134)=2.202, p=.029).  
Genetic test result 
Respondents to the English questionnaire were more likely than PIQ to 
experience negative feelings (2.9±0.9 versus 2.4±1.1; t(131)=2.596, 
p=.011), and to worry for relatives (2.8±0.9 versus 2.2±0.9; t(133)=2.557, 
p=.012). Participants who had received the information on their risk in an 
unplanned conversation/call were more likely to experience negative 
feelings about their genetic test result (3.0±0.8 versus 2.7±0.9; 
t(125)=2.060; p=.041). A positive test result significantly predicted higher 
frequency of negative feelings about test outcome (Q4,F1) (Betagene-found 
=.321) (F(11,111)=2.939, p=.002). Moreover, participants who received a 
positive test result were more likely to worry about their relatives (2.7±0.9 
versus 1.8±0.8; t(133)=3.316, p=.001); (Betagene-found =.213). Also having 
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children was a significant predictor of worrying about relatives (Q4,F4) 
(Betawith-children=.287), (F(11,113)=2.098, p=.026). Having being diagnosed 
with cancer significantly reduced the perception of the test as helpful 
(Q4,F5) (Betacancer=-.198) (F(11,111)=3.072, p=.001). 
Living with genetic risk 
Italian participants were more likely to perceive the influence of lifestage 
(2.2±1.1 versus 1.4±1.1; t(127)=-2.701, p=.008), as well as those who 
were diagnosed with cancer (Betacancer=.289). Conversely, having children 
predicted a lower perception of lifestage influence (Q5,F1) (Betawith-children=-
.285) (F(11,108)=3.211, p=.001). Participants who received a positive test 
result were significantly more likely to perceive it as helpful to their own 
prevention and for relatives than those who received a negative test result 
(3.0±0.8 versus 1.7±1.2; t(121)=3.343, p=.001) (Betagene-found=.332, 
F(11,102)=1.956, p=.041);  this was also true for participants who 
underwent PST between 18-25 years of age (2.0±0.7 versus 2.2±0.8; 
t(121)=2.127, p=.035) when compared to those tested at 26-30 years. 
Consistently, participants who received a positive test result were more 
likely to feel anxious than those who received a negative test result 
(2.2±0.7 versus 1.2±0.7; t(125)=3.043, p=.003) (Betagene-found=-.237, 
p=.012) (F(11,107)=2.246, p=.017). 
Parent questionnaire results 
The demographic information provided by the study participants is shown 
in Table 4. The majority of participants (n=25, 59.5%) had been previously 
diagnosed with cancer and 37 (88.1%) declared that there was a genetic 
tendency to cancer on their side of the family.  Among those, 35 (94.6%) 
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had a genetic test at 47.4±6.2 age of years. Ten (23.8%) of those who had 
a PST had never had cancer. 
Telling your children 
All participants reported that they had told their children about the family 
risk themselves; the age of the children when told ranged from 5-44 years 
(21.8±6.6). The majority (n=28, 66.7%) decided to disclose the information 
in a planned conversation with their child(ren), eight (19.0%) told them in a 
casual way, and six (14.3%) took advantage of a moment when the child 
raised the issue. Concerning parents’ reasons for telling their children 
about the family cancer risk, it was observed that participants who 
underwent genetic testing after having cancer were more likely to worry 
about the emotional impact on the child than those who underwent it 
before having cancer (2.3±1.1 versus 0.8±0.8; F=2.944, p=.050). 
However, participants who communicated the family cancer risk in a 
casual way to their children were less likely to have difficulties in 
communicating genetic status than those who planned a conversation with 
them (2.3±1.7 versus 1.0±1.1; F=4.164, p=.025).  Consistently, a 
significant difference was found between participants with a genetic 
tendency to cancer in their partner’s side of the family and participants 
with a genetic tendency in their own side of family: the first group were 
less likely to have difficulties in communicating genetic status (2.4±1.1 
versus 0.7±0.9; t(23)=3.952, p=.001).   
Children’s experience of the PST 
The majority (n=38, 94.7%) of parent participants told their children about 
the possibility of having a PST. Parents reported that the request for PST 
was made by the adult child themselves in 28 cases (73.7%), by the child 
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with one or both of the parents in five cases (13.2%), by the respondent or 
his partner in four cases (10.5%), and by the doctor in one case (2.6%). 
Parents’ feelings about PST for their children 
Guilt about the possibility that the mutation might be inherited by their 
children (parent questionnaire, question 80 in suppl. file) was more 
common in the mothers (Betamother=.349 R2.122). (F(1,34)=4.722, p=.037). 
However, all participants felt their children should be tested. The majority 
(n=26, 74.3%) also felt they had control over the decision their child made 
about the test.  
DISCUSSION 
The findings of this study suggest that young adults were told about the 
potential genetic risk at a mean age of 20±5.6 years.  This is older than 
the age of 13.5±2.6 years in the American sample described by Tercyak et 
al.24 and in general in the systematic review15, where about half were 
informed before the age of 18 years old and all before 21 years of age. 
However, no YA was younger than 12 years of age when informed15. In 
contrast, in our sample the large majority (75.5.%) were informed after 
their 18th birthday. The large majority (68.5%) received the information in 
an unplanned conversation and only 2% of our sample reported that 
genetic risk was openly discussed in their family. We did not collect data 
on the age at which parents were tested, so were not able to compare the 
age at which the child was informed with the parents at which parents 
received their own test result, but this would be interesting to study in 
future. Informal discussion about their potential genetic risk was preferred 
by young people described by Metcalfe et al.25 and in our sample parents 
were less likely to have difficulties in communicating genetic risk when it 
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happened in a casual way, as well as when they communicated the 
genetic risk of their partner’s side of the family. However, YA who were 
told about their genetic risk in an unplanned situation were more likely to 
report negative feelings about their genetic test result. It could be 
hypothesized that a communication perceived by a YA to be ‘casual’ may 
hamper the full understanding of the risk, thus increasing the chance of a 
negative emotional impact. The majority of parents reported that they 
disclosed the information in a planned conversation, while the majority of 
YA reported that discussions were not usually planned, and due to 
anonymity of participants, we were not able to determine if participants 
(both YA and parents) belonged to the same families. In any case, it may 
be that a conversation that was planned by parents may have appeared 
unplanned to their children. The fact that parents made the decision to 
disclose without involving health professionals is concerning as Borry et 
al.10 reported that parents were not able to transmit accurate information to 
their children regarding their genetic risk. It is possible that parents have 
not perceived the existence of support from genetic counsellors, even 
though Metcalfe et al.26 showed that health professionals are increasingly 
being asked for advice from parents about risk disclosure to their children. 
However, reluctance by parents to involve health professionals may be 
partly due to the parents’ wish to undertake this task alone26,27. While a 
previous systematic review15 suggested that positive and negative 
emotional outcomes were not correlated with test results, our participants 
who received a variant-positive test result were more likely to experience 
negative feelings. Although the majority of the requests for genetic testing 
were made by YA offspring, the majority of parent participants felt they 
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had control over the decision their child made about the test and all felt 
their children should be tested, which is in line with previous findings, 
where parents appeared to have exerted pressure on their children during 
the decision making process about testing15. These issues raise the 
ethical problem of how health professionals can respect young adults’ 
developing autonomy28–32. Werner-Lin et al.32 investigated genetic 
counsellors’ perspectives on counselling clients aged between 18-25 
years, using an online survey: a primary challenge reported was 
navigating family dynamics in counselling sessions. However, our findings 
show that YA who were strongly influenced by their parents to be tested 
were less likely to feel anxious. This result may confirm that YA did not 
completely understand the implications of the genetic test but complied 
because of parental pressure, and potentially felt relieved of the 
responsibility to make their own decisions.  An American study indicated 
that the current generation of YA have higher levels of student debt and 
are more likely to experience poverty and unemployment, while 53% of 
emerging adults aged 18-24 years currently lived with parents33,34. This is 
also true in Italy, where 62.5% of YA aged 18-34 years live with their 
nuclear families35,36. Living independently is one of the key developmental 
tasks of emerging adulthood37. If YA are co-resident with their parents, this 
could slow down the process of achieving autonomy as an adult. It is 
reasonable to hypothesise that this style of life has an impact on 
developmental tasks, reducing the autonomy of YA in their decision 
making. In fact, in our sample the number of PIQ who had been tested 
based on their own decision was significantly lower if compared to PEQ. 
However, genetic counsellors may have a responsibility to enable young 
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people to challenge decisions made by their parents that may be 
inappropriate for them38; it may be that parents do not always make the 
best possible decision for their offspring, but usually one that is intended to 
support them. In the context of PST, where there is uncertainty about the 
potential harm and/or benefits, Cohen believes that the parent’s decision 
should prevail over their offspring’s decision39. However, with regard to the 
principle of decision-making by a surrogate Buchanan and Brock40 
provided data on the fact that there may be a failure by parents to make a 
decision in the best interests of their children. The evidence of this study 
highlights the need for a comprehensive, longitudinal counselling process 
with appropriate timing and setting, which supports ‘parent-to-offspring’ 
risk communication first and YA’s decision making about PST and risk 
management afterwards.  This would include emphasising that disclosure 
of genetic risk is a gradual and dynamic process in the family, and where 
children are told at an early age, this should be followed with further age-
appropriate information. 
Strengths and limitations 
The limited number of PIQ reduced the possibility of observing differences 
between groups about their experience of PST.  This could be the result of 
difficulties in recruiting: only 39.3% of PIQ had accessed the questionnaire 
via the Internet, compared to 100% of PEQ. Another reason could be less 
interest in the Italian population regarding sharing information on medical 
issues via the Internet. Furthermore, the possibility of generalizing the 
results of factor analysis could be hampered by the small sample size41–45, 
particularly for the parent questionnaire. Moreover, almost all participants 
were variant-positive. It may be that potential participants who received 
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negative test results were no longer sufficiently interested in the topic to 
respond, or perceived that the topic was not relevant to them. Additionally, 
another limitation could be that data were collected retrospectively and not 
at the time of PST. Moreover, the choice of statistical tests and the SPSS 
outcomes were assessed by all the authors, who are experienced 
researchers, to maximise the validity of the analysis.  
Conclusions 
In conclusion, there is much research to do on this topic, and the results 
presented here need to be more fully explored. However, the findings of 
this study could contribute to improving clinical practice. They indicate a 
need both for publicising the supportive and educational role of genetic 
services. It is therefore important to emphasise that young adults may 
benefit from a multistep approach for undergoing genetic testing, and 
parents need to be more informed that genetic counselling is a place 
where information is obtained and young adults can freely talk about the 
decision, regardless of whether they want to be tested or not. 
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FIGURE 1: INCLUSION AND EXCLUSION CRITERIA 
 
 
Participants were eligible to take part in the study fitted either of the two groups below.  
1. Young adults who were: 
- aged 18-30 years when they underwent the presymptomatic genetic test for a 
familial cancer syndrome  
- without personal history of cancer when they underwent a presymptomatic 
genetic test and  
- members of families with a hereditary cancer predisposition. 
2. Parents of young adults who were tested between 18-30 years of age. 
 
Individuals in either group were ineligible if they were unable: 
- to provide informed consent due to mental incapacity or active psychotic illness or  
- unable to complete a survey in either English or Italian. 
56
Individuals logged into Italian surveys
42
Individuals logged into young 
adults' survey
12
Individuals logged into parents' 
survey
127 (70.2%) 
Young adult participants 
34 (75.6%)
Parent participants
25 (59.5%)
Young adult participants
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Parent participants 
42 
 
parents were eligible  
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young adults were eligible
No consent to be involved
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Under 18 years of age when they 
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Had no children who underwent 
genetic test 
All children under 18 years of age 
No genetic tendency to cancer
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- 
- 
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3 (1.7%) 
18 (9.9%) 
14 (7.3%) 
5 (11.1%)
3 (6.7%)
-
-
1 (2.2%)
1 (2.2%)
1 (2.2%)
No consent to be involved
Did not complete the minimum of 
30% 
Index cases 
Under 18 years of age when they 
underwent genetic test 
Had no children who underwent 
genetic test 
All children under 18 years of age 
No genetic tendency to cancer
 4 (9.5%) 
- 
- 
- 
- 
7 (16.7%) 
6 (14.3%) 
2 (16.7%)
4 (33.3%)
-
-
-
-
-
FIGURE 2 : RECRUITMENT FLOW-CHART 
 
 
 
 
 
 
 
 
228 
Individuals logged into English surveys
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individuals logged into young 
adults' survey
45 
Individuals logged into parents' 
survey
284
 
Individuals logged into 
 
TABLE 1: FACTORS FOR EACH QUESTION ANALYSED  
 
Q1: How did you react to the news that there might be a genetic condition in 
your family?” 
 STRONGLY OR 
SOMEWHAT 
DISAGREE
NEITHER 
AGREE NOR 
DISAGREE
STRONGLY OR 
SOMEWHAT 
AGREE 
Factor 1: Awareness    
I did not know what it really meant 31 (20.7%) 15 (10.0%) 104 (69.3%) 
I looked for information online 10 (6.8%) 15 (10.1%) 123 (83.1%) 
I was more conscious of my risk 36 (23.8%) 20 (13.2%) 95 (62.9%) 
I arranged the first counselling session to have 
a genetic blood test 
34 (54.0%) 24 (16.0%) 45 (30.0%) 
I felt it explained things I had been wondering 
about 
43 (28.9%) 46 (30.9%) 60 (40.3%) 
 
Factor 2: Need for information 
   
I arranged the first counselling session to 
discuss my risk 
81 (22.8%) 13 (8.7%) 102 (68.5%) 
I wanted to know some more about it at the 
time 
22 (14.7%) 16 (10.7%) 112 (74.7%) 
 
Q2: How did you feel about the genetic counselling? 
 STRONGLY OR 
SOMEWHAT 
DISAGREE
NEITHER 
AGREE NOR 
DISAGREE
STRONGLY OR 
SOMEWHAT 
AGREE
Factor 1: Satisfaction with genetic counselling    
The doctor or genetic counsellor showed an 
interest in your personal situation regarding 
the cancer family history 
14 (9.6%) 10 (6.8%) 123 (83.7%) 
The doctor or genetic counsellor explained your 
risk to you clearly 
12 (8.2%) 8 (5.4%) 123 (83.1%) 
The doctor or genetic counsellor met your 
expectations of him or her 
19 (13.0%) 14 (9.6%) 113 (77.4%) 
The doctor or genetic counsellor treated you as 
an individual 
15 (10.2%) 10 (6.8%) 122 (83.0%) 
You would be comfortable in calling the doctor 
or genetic counsellor to ask further questions 
27 (18.4%) 16 (10.9%) 104 (70.7%) 
The doctor or genetic counsellor listened to 
what you had to say 
14 (9.7%) 15 (10.3%) 116 (80.0%) 
The doctor or genetic counsellor was 
considerate of your emotional state during the 
meeting 
20 (13.7%) 16 (11.0%) 110 (75.3%) 
You are satisfied with the way that information 
was communicated to you 
21 (14.3%) 11 (7.5%) 115 (78.3%) 
The doctor or genetic counsellor understood 
what was really concerning you 
21 (14.5%) 14 (24.1%) 110 (75.8%) 
The doctor or genetic counsellor made you feel 
you were “in good hands” 
22 (15.1%) 14 (9.6%) 110 (75.3%) 
The doctor or genetic counsellor made you feel 
that they knew how to handle situations like 
your’s 
23 (15.6%) 15 (10.2%) 109 (74.1%) 
The doctor or genetic counsellor gave you 
enough of their time 
16 (10.9%) 13 (8.8%) 118 (80.3%) 
The doctor or genetic counsellor was sensitive 
and tactful during your conversation 
18 (12.2%) 8 (5.4%) 121 (82.3%) 
The doctor or genetic counsellor seemed to be 
an expert in the field 
19 (12.9%) 11 (7.5%) 117 (79.6%) 
The doctor or genetic counsellor helped you 
deal with any concerns you had 
19 (13.0%) 20 (13.7%) 107 (73.3%) 
You felt comfortable to talk about yourself 
during the genetic counselling session 
17 (11.6%) 16 (10.9%) 114 (77.5%) 
You were satisfied with the length of time you 
had to wait until your first appointment 
33 (22.6%) 19 (13.0%) 94 (64.4%) 
You were satisfied with the information your 
received during the genetic counselling 
appointment 
22 (15.0%) 11 (7.5%) 114 (77.5%) 
If a friend needed similar help you would 
recommend this clinic to him or her 
19 (13.0%) 18 (12.2%) 110 (74.8%) 
The counselling was given in an appropriate 
setting 
10 (6.8%) 11 (7.5%) 126 (85.7%) 
Overall you are satisfied with the genetic 
counselling service 
18 (12.2%) 14 (9.5%) 115 (78.3%) 
 
Q3: What were your reasons for wanting to be tested? 
 STRONGLY OR 
SOMEWHAT 
DISAGREE 
NEITHER AGREE 
NOR DISAGREE 
STRONGLY OR 
SOMEWHAT 
AGREE 
Factor 1: Proactivity    
I wanted to try to help advance research 20 (14.5%) 26 (18.8%) 87 (63.0%) 
I wanted to know if I need to get cancer 
screening tests more often 
4 (2.9%) 7 (5.1%) 113 (83.1%) 
I wanted to be reassured 9 (6.5%) 29 (21.0%) 92 (66.7%) 
I wanted to make a decision about surgery 
to reduce my risk 
13 (9.4%) 14 (10.1%) 97 (70.5%) 
I made my own decision 5 (3.6%) 8 (5.8%) 95 (68.8%) 
My decision was influenced by family 
experience 
14 (10.2%) 21 (15.3%) 88 (67.7%) 
Factor 2: Parents’ pressure against testing    
My mother warned me about having the 
test 
78 (60.0%) 26 (19.0%) 16 (11.7%) 
My father warned me about having the 
test 
88 (64.8%) 25 (18.4%) 8 (5.9%) 
My mother advised me to wait, but I 
decided to have it 
95 (68.8%) 16 (11.6%) 9 (6.5%) 
My father advised me to wait, but I 
decided to have it 
100 (74.8%) 15 (11.1%) 5 (3.8%) 
Factor 3: Parents’ decision to be tested     
I had genetic testing because of pressure 
from my family members 
99 (71.8%) 19 (13.8%) 16 (11.6%) 
I had genetic testing because my parent 
asked me to do it 
92 (66.7%) 23 (16.7%) 17 (12.3%) 
Factor 4:  Concern for children    
I wanted to learn about my children’s risk 
or risks to any children I may have 
10 (7.3%) 19 (13.9%) 92 (67.1%) 
I wanted to make a decision about having 
(more) children 
34 (24.8%) 26 (19.0%) 59 (43.2%) 
Factor 5: Parent’s pressure for testing    
My mother strongly encouraged me 35 (25.3%) 31 (22.5%) 59 (42.7%) 
My father strongly encouraged me 44 (32.3%) 36 (26.4%) 44 (32.3%) 
 
Q4: How did you feel after receiving your genetic test result? 
 STRONGLY OR 
SOMEWHAT 
DISAGREE 
STRONGLY OR 
SOMEWHAT 
AGREE 
Factor 1: Negative feelings   
I felt upset about my test result 36 (26.7%) 99 (73.3%) 
I felt sad about my test result 27 (20.0%) 108 (80.0%) 
I felt anxious or nervous about my test result 40 (29.6%) 95 (70.4%) 
I was more worried about my risk of getting cancer 28 (20.7%) 107 (79.2%) 
I felt a loss of control 70 (51.5) 66 (48.5%) 
Factor 2: Negative impact on relationships   
I felt guilty about my test result 95 (69.8%) 41 (30.1%) 
I had problems enjoying life because of my test result 84 (62.2%) 51 (37.5%) 
I was worried other people might discuss this behind my 
back 
114 (85.1%) 20 (14.9%) 
I was worried other people might think less of me 
because of my result 
114 (83.8%) 22 (16.2%) 
I felt more distant from family members 115 (84.6) 21 (15.4%) 
Factor 3: Uncertainties about the meaning of test result   
I was uncertain about what my test result meant for my 
cancer risk 
112 (82.4%) 24 (17.6%) 
I was uncertain about what my test result meant for my 
children or any children I may have 
103 (76.8%) 31 (23.2%) 
I was uncertain about what my test result meant for my 
family’s cancer risk 
106 (78.5%) 29 (21.5%) 
Factor 4: Worry for relatives   
I was worried because of the possibility of passing the 
mutation to my children or any children I may have 
23 (17.0%) 112 (83.0%) 
I felt guilty about my family 87 (64.0%) 49 (36.0%) 
Factor 5:  Perceiving the test as helpful   
I felt relieved about my test result 83 (61.5%) 52 (38.5%) 
I felt able to plan my future 42 (31.1%) 93 (68.9%) 
 
Q5: How did you feel living with your genetic risk? 
 STRONGLY OR 
SOMEWHAT 
DISAGREE 
STRONGLY OR 
SOMEWHAT 
AGREE 
Factor 1: Influence on lifestage perception    
I have wondered about when to share my genetic risk 
with a new partner 
46 (35.4%) 42 (32.4%) 
I have wondered about how early in a relationship to 
discuss having children 
47 (35.9%) 37 (28.2%) 
I have wondered about how early in a relationship to 
discuss surgery to reduce my risk 
46 (35.1%) 42 (32.0%) 
I try not to think about the cancer risk because I am too 
young yet for screening 
69 (53.1%) 32 (24.6%) 
Factor 2: Impact of test result on own prevention and 
on relatives 
 
 
Having time before the regular cancer screening was due 
to start gave me the opportunity to think about it 
26 (20.1%) 86 (66.7%) 
Having time before the cancer screening was due to start 
gave me the opportunity to think about having surgery 
to reduce my risk 
29 (11.6%) 95 (73.6%) 
I understood my choice for cancer prevention or early 
detection clearly 
10 (7.8%) 111 (87.7%) 
I felt frustrated that there are no ways I can completely 
prevent cancer 
32 (24.4%) 89 (68.0%) 
I felt satisfied with family communication about my 
genetic test result 
24 (18.7%) 96 (74.4%) 
I was worried about the possibility of my children (or any 
children I may have) getting cancer 
12 (9.3%) 103 (79.3%) 
I was feeling guilty about possibly passing on the disease 
risk to my children or any children I may have 
22 (16.8%) 92 (70.3%) 
Factor 3: Anxiety   
I was having difficulty making decisions about cancer 
screening or measures to reduce my risk 
89 (68.4%) 33 (25.4%) 
I thought about having risk -reducing surgery sooner 
rather than later 
27 (20.7%) 90 (69.3%) 
My parents strongly encouraged me to have surgery to 
reduce my risk of cancer 
78 (59.5%) 30 (23.0%) 
Thinking about my test result has affected my work or 
family life 
58 (44.3%) 66 (50.4%) 
I had difficulty talking about my test results with family 
members 
95 (73.8%) 30 (23.8%) 
I decided to limit the number of children I have because I 
may pass on the mutation 
70 (53.5%) 40 (30.6%) 
I feel anxious waiting for the first or next screening 29 (22.4%) 83 (63.8%) 
Factor 4: Protection of self and children   
I regretted my choice to have children 73 (56.6%) 12 (9.4%) 
I try to do all I can to stay alive for my children 6 (4.6%) 75 (58.2%) 
I have confidence in the cancer screening procedures 28 (21.6%) 95 (73.8%) 
 
Q6: What were your reasons for telling or not telling your children about the 
family cancer risk? 
 STRONGLY OR 
SOMEWHAT 
DISAGREE 
NEITHER 
AGREE NOR 
DISAGREE 
STRONGLY OR 
SOMEWHAT 
AGREE 
Factor 1: Making children aware    
I wanted to provide access to information 
for my children 
4 (10.0%) 2 (5.0%) 34 (85.0%) 
I wanted to make my children aware of 
the risk 
4 (10.0%) 2 (5.0%) 34 (85.0%) 
I wanted to share my genetic test results 
with my children so they could be tested 
4 (10.3%) 1 (2.6%) 36 (90.0%) 
I wanted to explain the family history of 
cancer 
4 (10.3%) 3 (7.7%) 32 (80.0%) 
I wanted to share my genetic test results 
with my children because of my 
grandchildren or future grandchildren 
4 (10.0%) 6 (15.0%) 27 (67.5%) 
I felt it was the appropriate age to tell 
them 
5 (12.8%) 4 (10.3%) 30 (76.9%) 
I wanted them to be able to have 
screening 
4 (10.5%) 1 (2.6%) 32 (88.9%) 
I thought my children were too young to 
know 
22 (61.1%) 1 (2.8%) 3 (8.3%) 
I was not ready to share the news 26 (70.3%) 2 (5.4%) 4 (10.8%) 
There was no medical reason to tell them 28 (77.8%) 1 (2.8%) 1 (2.8%) 
    
Factor 2: Worry about  emotional impact 
on children 
  
 
I thought it might make my children 
anxious 
16 (43.2%) 7 (18.9%) 10 (27.8%) 
I thought it might increase my children’s 
fear of getting cancer 
19 (51.4%) 3 (8.1%) 11 (29.7%) 
I thought it might increase my children’s 
worry about my and my partner’s health 
16 (43.2%) 7 (18.9%) 10 (27.0%) 
I am still coping with the test results 21 (56.8%) 3 (8.1%) 8 (21.6%) 
    
Factor 3: Difficulties in communicating 
own genetic status 
   
I wanted to share my partner’s genetic 
test results with my children so they could 
be tested 
2 (5.6%) 1 (2.8%) 9 (22.5%) 
I wanted to share my partner’s genetic 
test results with my children because of 
my grandchildren or future grandchildren 
2 (5.6%) 1 (2.8%) 9(25.0%) 
I didn’t intend to tell them but they 
accidentally found out 
19 (52.8%) 1 (2.8%) 1 (2.8%) 
I thought it was unnecessary to make my 
children aware of the family history 
27 (73.0%) 1 (2.7%) 4 (10.8%) 
 
TABLE 2 (A): MULTIPLE LINEAR REGRESSION ANALYSIS OF FACTORS IDENTIFIED BY EFA 
 Q1: How did you react to the news that there might be a genetic condition in 
your family?” 
Q2: How did you feel about the 
genetic counselling? 
 Factor 1: Awareness Factor 2: Need for information Factor 1: Satisfaction with genetic 
counselling 
 B SE B Beta B SE B Beta B SE B Beta
Gender -.224 1.791 -.012 -.331 .931 -.033 -.685 9.599 -.007 
Age -.116 .084 -.152 -.022 .043 -.055 -.247 .464 -.062 
Having children -.896 .909 -.103 -.139 .459 -.031 4.207 4.942 .092 
Age at PST .059 .814 .007 .308 .418 .069 6.315 4.429 .137
PST result 2.871 1.770 .147 .834 .918 .083 8.912 9.440 .087 
Having cancer 1.184 1.567 .068 -.783 .772 -.092 -14.680 8.349 -.162 
YA told by first-degree 
relatives -4.616 2.130 -.514* -1.259 1.107 -.274 -4.446 11.423 -.093 
YA told by distant relatives -4.276 2.329 -.358 -.672 1.211 -.109 -6.356 12.542 -.100 
YA told by members 
outside the family -3.077 2.153 -.272 -.945 1.116 -.164 7.183 11.552 .119 
How YA received the 
information -.035 .924 -.004 -.586 .479 -.120 -.363 5.146 -.007 
Age at information 
received were entered into 
YA models 
-2.174 .910 -.211* -1.013 460 -.195* -5.375 4.755 -.102 
 F(11,121)=1.587, p=.111 F(11,125)=1.144, p=.333 F(11,119)=1.275, p=.247
 
TABLE 2 (B): MULTIPLE LINEAR REGRESSION ANALYSIS OF FACTORS IDENTIFIED BY EFA 
 Q3: What were your reasons for wanting to be tested? 
 Factor 1: Proactivity Factor 2: Parents’ 
pressure against testing 
Factor 3: Parents’ 
decision to be tested 
Factor 4:  Concern for 
children 
Factor 5: Parent’s 
pressure for testing 
 B SE B Beta B SE B Beta B SE B Beta B SE B Beta B SE B Beta 
Gender 1.313 1.215 .128 -2.335 1.784 -.141 -.4.303 .947 -.410** .104 .993 .011 
-
2.412 1.252 -.194 
Age .059 .066 .123 -.046 .085 -.074 .056 .044 .130 -.082 .049 -.222 -.019 .058 -.040
Having children -
1.113 .671 -.215 -.600 .850 -.084 -1.288 .480 
-
.264** .689 .516 .159 
-
1.104 .592 -.210 
Age at PST -.214 .607 -.041 1.867 .761 .260* 1.022 .432 .208* .567 .467 .130 .943 .538 .178
PST result .439 1.328 .039 .734 1.765 .044 .067 .869 .007 .792 .964 .085 1.382 1.123 .121 
Having cancer 1.694 1.106 .177 2.827 1.469 .200 .886 .839 .090 1.501 .800 .195 .208 .966 .021 
YA told by first-degree 
relatives 
-
2.678 1.548 -.509 -4.220 2.180 -.572 1.002 1.087 .199 -.310 1.188 -.070 3.164 1.567 .586* 
YA told by distant relatives -
2.385 1.685 -.364 -5.910 2.301 -.617* .379 1.194 .057 .459 1.287 .078 1.871 1.637 .267 
YA told by members 
outside the family 
-
1.538 1.541 -.224 -4.075 2.206 -.435 .615 1.100 .095 .354 1.210 0.63 3.670 1.576 .546* 
How YA received the 
information -.372 .708 -.065 -.158 .910 -.020 -.053 .515 .010 .059 .553 .012 .111 .631 .019 
Age at information 
received were entered 
into YA models 
.793 .656 .133 -1.875 .881 -.220* -1.048 .480 -.183* -.375 .509 -.074 -1.358 .598 -.222* 
 F(11,76)=1.610, 
p=.113 F(11,90)=2.028, p=.034 F(11,110)=4.368, p<.001 
F(11,93)=1.375, 
p=.198 F(11,94)=2.606, p=.006 
      
TABLE 2 (C): MULTIPLE LINEAR REGRESSION ANALYSIS OF FACTORS IDENTIFIED BY EFA 
 Q4: How did you feel after receiving your genetic test result? 
 Factor 1: Negative 
feelings 
Factor 2: Negative impact 
on relationships 
Factor 3: Uncertainties 
about the meaning of 
test result 
Factor 4: Worry for 
relatives 
Factor 5:  Perceiving the 
test as helpful 
 B SE B Beta B SE B Beta B SE B Beta B SE B Beta B SE B Beta 
Gender 2.878 1.638 .167 1.456 1.345 .112 .213 1.035 .020 -.279 .729 -.037 -.492 .697 -.066 
Age .044 .081 .061 .013 .070 .023 -.032 .052 -.072 -.056 .037 -.176 -.033 .036 -.105 
Having children -.926 .898 -.109 -.635 .754 -.099 .592 .578 .115 1.064 .401 .287** .751 .383 .205
Age at PST .405 .794 .048 .056 .652 .009 .571 .505 .111 .574 .353 .154 -.055 .338 -.015 
PST result 5.891 1.719 .321** .855 1.308 .066 -.338 1.005 -.033 1.612 .710 .213* 1.204 .722 .153 
Having cancer -.518 1.458 -.032 1.179 1.209 .096 3.137 .928 .319* 1.255 .655 .175 -1.392 .623 -.198*
YA told by first-
degree relatives 1.441 2.002 .166 .466 1.659 0.72 .465 1.273 .089 -.149 .899 -.039 -.233 .930 -.062 
YA told by 
distant relatives 1.358 2.189 .120 1.190 1.812 .140 .074 1.394 .011 -.232 .984 -.047 -.457 .990 -.094 
YA told by 
members 
outside the 
family 
-.447 2.004 -.041 .791 1.659 .098 1.004 1.271 .155 .393 .898 .084 -1.842 .934 -.399 
How YA received 
the information .790 .938 .084 -.176 .778 -.025 .236 .600 .042 .163 .421 .040 -.320 .403 -.079 
Age at 
information 
received were 
entered into YA 
models 
-.249 .866 -.025 -.651 .730 -.086 -.014 .554 -.002 -.203 .389 -.524 -.207 .370 -.049 
 F(11,111)=2.939, p=.002 F(11,111)=.640, p=.791 F(11,111)=1.561, p=.120 F(11,111)=2.939, p=.002 F(11,111)=3.072, p=.001
  
TABLE 2 (D): MULTIPLE LINEAR REGRESSION ANALYSIS OF FACTORS IDENTIFIED BY EFA 
 Q5: How did you feel living with your genetic risk? 
 
Factor 1: Influence on 
lifestage perception  
Factor 2: Impact of test result 
on own prevention and on 
relatives 
Factor 3: Anxiety Factor 4: Protection of self and children 
 B SE B Beta B SE B Beta B SE B Beta B SE B Beta
Gender .058 1.765 .003 -1.743 2.632 -.066 4.030 2.089 .182 -.359 1.122 -.108 
Age -.073 .089 -.094 -.081 .123 -.081 -.026 .105 -.030 -.070 .057 -.138 
Having children -2.594 .979 -.285** 1.372 1.351 .116 -.660 1.162 -.064 2.956 .621 .498** 
Age at PST 1.114 .847 .121 2.268 1.177 .190 1.509 1.005 .144 .279 .540 .047
PST result 1.671 1.867 .080 9.587 2.899 .332** 5.630 2.215 .237* 1.000 1.189 .074 
Having cancer 5.002 1.544 .289** 2.754 2.116 .125 3.607 1.830 .184 2.989 .982 .266** 
YA told by first-
degree relatives .253 2.315 -.027 -.135 3.163 -.011 -.735 2.744 -.069 -1.658 1.472 -.273 
YA told by distant 
relatives -.215 2.463 -.018 -.230 3.386 -.015 .491 2.916 .036 -1.452 1.576 -.183 
YA told by members 
outside the family -1.331 2.312 -.117 -1.719 3.182 -.115 -.752 2.757 -.056 -1.842 1.476 -.245 
How YA received the 
information -1.656 1.050 -.162 -2.429 1.484 -.183 -.319 1.258 -.027 .068 .683 .010 
Age at information 
received were 
entered into YA 
models 
.082 .925 .008 .344 1.297 .025 -.497 1.110 -.041 -.299 .596 -.043 
 F(11,108)=3.211, p=.001 F(11,102)=1.956, p=.041 F(11,107)=2.246, p=.017 F(11,107)=3.815, p<.001 
     
TABLE 2 (E): MULTIPLE LINEAR REGRESSION ANALYSIS OF FACTORS IDENTIFIED BY EFA 
 Q6: What were your reasons for telling or not telling your children about the family cancer risk? 
 Factor 1: Making children aware Factor 2: Worry about  emotional impact on children 
 B SE B Beta B SE B Beta 
Gender -7.238 14.655 -.260 -6.308 3.818 -.496 
Age -.087 .846 -.089 -.249 .284 -.476
Having cancer 8.872 11.184 .478 3.037 2.744 .356 
Age at PST -.207 .907 -.177 -.001 .336 -.003 
Being the first person tested in the 
family 1.169 9.395 .063 1.096 2.736 .126 
Way of communication to children 3.632 10.494 .171 1.289 2.396 .144 
PST requested by children 15.562 11.476 .784 -1.813 3.069 -.196
PST requested by parents 18.256 13.078 .774 -4.791 3.690 -.377 
 F(8,7)=.451, p=.856 F(8,15)=.951, p=.527
*p<.05 
**p<.01 
Multiple linear regression was not performed for factor 3 because the assumptions 
 
TABLE 3: SAMPLE CHARACTERISTICS: YOUNG ADULT PARTICIPANTS 
  ALL
(N=152) 
PEQ§
(N=127) 
PIQ§ 
(N=25) 
p-value 
Age at questionnaire (years) 
 mean±SD 29.5±5.6 29.6±5.9 28.7±3.7 0.463 a
Age at PST  (years) 
 mean±SD 24.7±3.7 24.7±3.8 25.0±3.4 0.700 a 
Gender 
 Male 
Female 
I prefer not to say 
11 (7.2%) 
140 (92.1%) 
1 (0.7%) 
2 (1.6%) 
124 (97.6%) 
1 (0.8%) 
9 (36.0%) 
16 (64.0%) 
0 
0.000b,* 
Country 
 Italy 
United Kingdom 
United States of America 
Other countries 
25 (16.4%) 
63 (41.4%) 
47 (30.9%) 
17 (11.2%) 
0 
63 (49.6%) 
47 (37.0%) 
17 (13.4%) 
25 (100%) 
0 
0 
0 
- 
Education 
 Primary school 
Secondary school 
Post-secondary educ. 
University degree 
Postgraduate degree 
1 (0.7%) 
15 (9.9%) 
49 (32.2%) 
62 (40.8%) 
25 (16.4%) 
1 (0.8%) 
15 (11.8%) 
38 (29.9%) 
50 (39.4%) 
23 (18.1%) 
0 
0 
11 (44.0%) 
12 (48.0%) 
2 (8.0%) 
0.191b 
Daily work 
 Paid employment 
Voluntary employment 
Student 
Homemaker 
Not working not student 
112 (73.7%) 
2 (1.3%) 
18 (11.8%) 
15 (9.9%) 
5 (3.3%) 
94 (74.0%) 
1 (0.8%) 
13 (10.2%) 
15 (11.8%) 
4 (3.1%) 
18 (72.0%) 
1 (4.0%) 
5 (20.0%) 
0 
1 (4.0%) 
0.176b 
Marital status 
 Single (never married) 
Married 
Divorced 
Living with a partner 
48 (31.6&) 
67 (44.1%) 
7 (4.6%) 
30 (19.7%) 
33 (26.0%) 
60 (47.2%) 
6 (4.7%) 
28 (22.0%) 
15 (60.0%) 
7 (28.0%) 
1 (4.0%) 
2 (8.0%) 
0.009b 
Children 
 Yes 
No 
73 (48.0%) 
79 (52.0%) 
69 (54.3%) 
58 (45.7%) 
4 (16.0%) 
21 (84.0%) 
0.000c 
Condition tested     
 Cowden syndrome 
Familial adenomatous polyposis 
Hereditary breast and ovarian cancer 
Lynch syndrome 
1 (0.7%) 
14 (9.2%) 
111 (73.0%) 
26 (17.1%) 
   
 
§ PEQ was used to indicate the participants responding to the English questionnaire and PIQ the participants responding to the Italian 
questionnaire 
* “I prefer not to say” answer was excluded from the analysis 
a Independent samples T-test 
b Pearson chi-squared test 
c Fisher's exact test 
 
 
 
 
 
TABLE 4: SAMPLE CHARACTHERISTICS: PARENT PARTICIPANTS 
 ALL 
(N=42) 
PEQ 
(N=34) 
PIQ 
(N=8) 
p-value 
Age at questionnaire (years)   
mean±SD 51.9±7.6 51.7±7.3 55.1±3.8 0.211 a 
Gender     
 Male 
Female 
4 (9.5%) 
38 (90.5%) 
4 (100.0%) 
30 (78.9%) 
0 
8 (21.1%) 
0.572c 
Country     
 Italy 
United Kingdom 
United State of America 
Other countries 
8 (19.0%)
17 (40.5%) 
11 (26.2%) 
6 (14.3%) 
0
17 (50.0%) 
11 (32.4%) 
6 (17.6%) 
8 (100.0%) 
0 
0 
0 
-
Education     
 Secondary school 
Post-secondary educat. 
University degree 
Postgraduate degree 
10 (23.8%)
20 (47.6%) 
7 (16.7%) 
5 (11.9%) 
9 (26.5%)
15 (44.1%) 
5 (14.7%) 
5 (14.7%) 
1 (12.5%) 
5 (62.5%) 
2 (25.0%) 
0 
0.461b
Daily work     
 Paid employment 
Homemaker 
Not working not student 
29 (69.0%)
7 (16.7%) 
6 (14.3%) 
23 (67.6%)
5 (14.7%) 
6(17.6%) 
6 (75.0%) 
2 (25.0%) 
0 
0.392b
Marital status     
 Single (never married) 
Married 
Married 
Living with a partner 
1 (2.9%) 
32 (76.2%) 
8 (19.0%) 
1 (2.4%) 
1 (2.9%) 
24 (70.6%) 
8 (23.5%) 
1 (2.3%) 
0 
8 (100.0%) 
0 
0 
0.378b 
Condition tested 
 Cowden syndrome 
Familial adenomatous polyposis 
Hereditary breast and ovarian cancer 
Lynch syndrome 
4 (11.4%) 
1 (2.9%) 
24 (68.6%) 
6 (17.1%) 
   
a Independent samples T-test 
b Pearson chi-squared test 
c Fisher's exact test 
 
